| Systemic Lupus Erythematosus: A Companion to Rheumatology, 1e |  | Authors: George C. Tsokos, Caroline Gordon, Josef S. Smolen MD
Publisher: Mosby
Category: Book
List Price: $146.95
Buy New: $126.17
as of 5/26/2012 11:49 EDT details
You Save: $20.78 (14%)
New (15) Used (10) from $55.00
Seller: pbshop
Sales Rank: 1,240,144
Languages: English (Unknown), English (Original Language), English (Published)
Media: Hardcover
Edition: 1
Pages: 608
Number Of Items: 1
Shipping Weight (lbs): 3.2
Dimensions (in): 10.5 x 7.5 x 1.1
ISBN: 0323044344
EAN: 9780323044349
ASIN: 0323044344
Publication Date: January 18, 2007
Availability: Usually ships in 1-2 business days
| |
| Also Available In:
| |
| Editorial Reviews:
Product Description
This new companion to Hochberg et al.'s Rheumatology masterwork provides new insights into the causes, detection and therapy of this challenging disease. In this state-of-the-art resource, you'll find 'one stop' coverage of all the latest scientific and clinical developments in SLE: new concepts in epidemiology, disease activity measures and outcomes; new concepts in immunoregulation, genetic and pathogenic mechanisms; new understanding and novel presentation of the processes of tissue/organ damage; comprehensive coverage of clinical features; and the very latest concepts in treatment.- Provides the very latest understanding of the pathogenesis of SLE.
- Distills current understanding of the cellular, molecular, genetic and environmental factors that instigate and drive the disease.
- Includes comprehensive coverage of clinical features, including fatigue, organ system manifestations, overlap syndromes, infections, and more.
- Conveys the very latest understanding of mechanisms of tissue damage, including immune complexes, antibodies, and other mechanisms that lead to organ damage.
- Contains expert discussion of processes that are responsible for tissue injury - a hallmark of this text.
- Incorporates the latest treatment modalities, including steroids and non-steroidals, cytotoxic drug treatment, PAP's, and therapies on the horizon.
- Discusses the latest treatment options on disease modifying or disease controlling agents.
|
| |
|
|
|
CERTAIN CONTENT THAT APPEARS ON THIS SITE COMES FROM AMAZON SERVICES LLC. THIS CONTENT IS PROVIDED ‘AS IS’ AND IS SUBJECT TO CHANGE OR REMOVAL AT ANY TIME. Powered by Associate-O-Matic
| |
